Treatment of inflammatory disorders with triazole compounds

Details for Australian Patent Application No. 2007207607 (hide)

Owner Barrier Therapeutics, Inc.

Inventors Borgers, Marcel; Cools, Marina

Agent Stiefel Research Australia Pty Ltd

Pub. Number AU-B-2007207607

PCT Pub. Number WO2007/084542

Priority 60/759,027 17.01.06 US

Filing date 17 January 2007

Wipo publication date 26 July 2007

Acceptance publication date 19 April 2012

International Classifications

A01N 43/78 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/425 (2006.01) - Thiazoles

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/084542 Priority application(s): WO2007/084542

19 April 2012 Application Accepted

  Published as AU-B-2007207607

31 May 2012 Assignment before Grant

  Barrier Therapeutics, Inc. The application has been assigned to Stiefel Laboratories, Inc.

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207609-Methods of treating or preventing tissue damage caused by increased blood flow

2007207606-Central administration of stable formulations of therapeutic agents for CNS conditions